Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines

AJ Pollard, KP Perrett, PC Beverley - Nature Reviews Immunology, 2009 - nature.com
Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and
pneumonia in children. The use of protein–polysaccharide conjugate vaccines in developed …

The global impact of vaccines containing aluminium adjuvants

CJ Clements, E Griffiths - Vaccine, 2002 - Elsevier
Immunization against childhood vaccine-preventable diseases has arguably had the
greatest impact on the health of children of any public health intervention. Many of the …

[HTML][HTML] A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States

EE Mast, HS Margolis, AE Fiore, EW Brink… - MMWR, 2005 - cdc.gov
Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV)
infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and …

Combination vaccines

MD Decker - Primary Care: Clinics in Office Practice, 2001 - primarycare.theclinics.com
The present rapid growth in the availability of safe and effective vaccines provides a
continuing need to expand and simplify vaccine administration programs. The replacement …

Principles of pediatric combination vaccines and practical issues related to use in clinical practice

MD DECKER - The Pediatric infectious disease journal, 2001 - journals.lww.com
Background. During the past two decades the number of injections that are required per
office visit to fulfill the recommended childhood immunization schedule has increased …

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines

P Bonanni, S Boccalini, A Bechini… - Human Vaccines & …, 2020 - Taylor & Francis
Simultaneous administration of different vaccines is a strategy to increase the possibility to
receive vaccines at appropriate age, safely and effectively, reducing the number of sessions …

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults

JR Casey, ME Pichichero - Drugs, 2005 - Springer
This review offers a perspective on the acellular pertussis vaccine efficiency trials concluded
in the 1990s and presents the main conclusions of a meta-analysis of 52 studies that …

Development and clinical application of new polyvalent combined paediatric vaccines

FE André - Vaccine, 1999 - Elsevier
The availability of combined vaccines containing protective antigens against the majority of
(ideally all) diseases for which universal immunization is recommended in infancy would …

Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age …

DP Greenberg, VK Wong, S Partridge… - The Pediatric …, 2002 - journals.lww.com
Objective. To evaluate the safety and immunogenicity of diphtheria-tetanus toxoids-acellular
pertussis (DTPa)-hepatitis B (HepB) combination vaccine given at 2, 4 and 6 months of age …

Safety of immunization and adverse events following vaccination against hepatitis B

P Duclos - Journal of Hepatology, 2003 - Elsevier
Second only to tobacco as a recognized cause of a major cancer in humans, hepatitis B is
preventable with safe and effective vaccines [1]. In 2000, according to World Health …